logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
B

Bronno van der Holt

University Medical Center Rotterdam
H指数:69
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients

EMN12/HOVON-129研究移植适宜队列中初发浆细胞白血病患者长期随访

Blood Cancer Journal
IF11.6
2026-06-240
OAAI
Niels W. C. J. van de Donk; Fredrik Schjesvold; Bronno van der Holt; Monique C. Minnema; Ka Lung Wu; Annemiek Broijl; Wilfried W. H. Roeloffzen; Alain Gadisseur; Giuseppe Pietrantuono; Ludek Pour; Vincent H. J. van der Velden; Thomas Lund; Massimo Offidani; Sara Bringhen; Luisa Giaccone; Wida Razawy; Paola Tacchetti; Katia Mancuso; Trine Silkjaer; Jo Caers; Sonja Zweegman; Roman Hájek; Reuben Benjamin; Annette Juul Vangsted; Mario Boccadoro; Francesca Gay; Pieter Sonneveld; Pellegrino Musto
Fixed-duration ibrutinib–venetoclax with MRD-guided ibrutinib–obinutuzumab intensification in first-line chronic lymphocytic leukaemia (HOVON 158/NEXT STEP): primary analysis of a multicentre, open-label, phase 2 trial

固定疗程的ibrutinib–venetoclax联合MRD指导的ibrutinib–obinutuzumab在一线慢性淋巴细胞白血病中的强化治疗（HOVON 158/NEXT STEP）：一项多中心、开放标签、II期试验的主要分析

The Lancet Haematology
IF0
2025-12-010
PRE
Arnon P Kater; Sabina Kersting; Julie M Dubois; Bronno van der Holt; Caspar da Cunha-Bang; Doreen te Raa; Cecile Idink; Fransien de Boer; Jolanda Droogendijk; Koen de Heer; Leonie van der Burg; Marten R Nijziel; Lidwien Tick; Henriette Levenga; Matthijs Silbermann; Inge Ludwig; Aart Beeker; Mar Bellido; Johan A Dobber; Ludo M Evers
Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOPANC-1 and-2 trials

胰腺癌手术后胃排空延迟影响辅助治疗开始时间，但不影响总生存期：一项对PREOPANC-1和-2试验的事后分析

BJS-BRITISH JOURNAL OF SURGERY
IF0
2025-12-010
PRE
Strijbos, Bo T. M.; Kraakman, Imme; Hopstaken, Jana S.; van Dongen, Jelle C.; Janssen, Quisette P.; van Dam, Jacob L.; Akkermans-Vogelaar, Janine M.; Besselink, Marc G.; Bonsing, Bert A.; Bos, Hendrik; Bosscha, Koop P.; Buijsen, Jeroen; Busch, Olivier R.; van Dam, Ronald M.; Eskens, Ferry A. L. M.; Festen, Sebastiaan; de Groot, Jan W. B.; Groothuis, Karin; Haberkorn, Brigitte C. M.; de Hingh, Ignace H. J. T.; van der Holt, Bronno; Homs, Marjolein Y., V; van Hooft, Jeanin E.; Karsten, Tom M.; Kerver, Emile D.; van der Kolk, Marion B.; van Laarhoven, Cornelis J. H. M.; Liem, Mike S. L.; Luelmo, Saskia A. C.; Neelis, Karen J.; Nuyttens, Joost; Paardekooper, Gabriel M. R. M.; Patijn, Gijs A.; van der Sangen, Maurice J. C.; van Santvoort, Hjalmar C.; Streppel, Mirte M.; Suker, Mustafa; Versteijne, Eva; Vissers, Pauline A. J.; de Vos-Geelen, Judith; Wilmink, Johanna W.; Zwinderman, Aeilko H.; van Eijck, Casper H. J.; van Tienhoven, Geertjan; Groot Koerkamp, Bas; Stommel, Martijn W. J.
Adaptive designs in randomized clinical trials: reanalysis of the HOVON87/NMSG18 multiple myeloma trial

随机临床试验中的适应性设计：HOVON87/NMSG18多发性骨髓瘤试验的再分析

eClinicalMedicine
IF10
2025-10-300
OAAI
Maarten R. Seefat; Niek G. van der Maas; Kazem Nasserinejad; Bronno van der Holt; Anders Waage; Ulf-Henrik Mellqvist; Annette Juul Vangsted; Anna J.T. Smit; Febe Smits; Paula F. Ypma; Niels W.C.J. van de Donk; Hedwig M. Blommestein; Jan J. Cornelissen; David G.J. Cucchi; Sonja Zweegman; Jurjen Versluis
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial

新辅助FOLFIRINOX与基于吉西他滨的新辅助化放疗在可切除和边界可切除胰腺癌中的比较（PREOPANC-2）：一项多中心、开放标签、III期随机试验

lancet oncology
IF0
2025-09-100
PRE
Quisette P Janssen; Jacob L van Dam; Marlies L van Bekkum; Bert A Bonsing; Hendrik Bos; Koop P Bosscha; Stefan A W Bouwense; Lieke Brouwer-Hol; Anna M E Bruynzeel; Olivier R Busch; Peter-Paul L O Coene; Casper H J van Eijck; Jan Willem B de Groot; Brigitte C M Haberkorn; Ignace H J T de Hingh; Tom M Karsten; Geert Kazemier; Marion B van der Kolk; Mike S L Liem; Olaf J L Loosveld; Saskia A C Luelmo; Misha D P Luyer; Leonie J M Mekenkamp; J Sven D Mieog; Vincent B Nieuwenhuijs; Joost J M E Nuyttens; Gijs A Patijn; Hjalmar C van Santvoort; Martijn W J Stommel; Eva Versteijne; Judith de Vos-Geelen; Roeland F de Wilde; Babs M Zonderhuis; Bronno van der Holt; Marjolein Y V Homs; Geertjan van Tienhoven; Marc G Besselink; Johanna W Wilmink; Bas Groot Koerkamp
Mobilization of hematopoietic stem cells using G-CSF with or without cyclophosphamide before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma receiving induction therapy with or without daratumumab

使用G-CSF联合或不联合环磷酰胺在自体干细胞移植前动员造血干细胞，用于接受含或不含达雷木单抗诱导治疗的新诊断多发性骨髓瘤患者

Bone Marrow Transplantation
IF5.2
2025-08-300
PRE
Cathelijne Fokkema; Marjolein K. Appelman; Niels Veldhoen; Annie Spelt; Bronno van der Holt; Meriam Grootes; Ruth Wester; Emma de Pater; Paula F. Ypma; Annoek E. C. Broers; Pieter Sonneveld; Annemiek Broijl
Primary percutaneous stenting above the ampulla versus endoscopic drainage for unresectable malignant hilar biliary obstruction (TESLA RCT): study protocol for a multicenter randomized controlled trial

经皮支架置入（胆总管括约肌上）与内镜引流治疗不可切除性恶性肝门部胆道梗阻（TESLA随机对照试验）：一项多中心随机对照试验研究方案

BMC CANCER
IF3.4
2025-05-090
OA
Rousian, M.; van Verschuer, V.; Franssen, S.; Bijdevaate, D.; Bokkers, R. P. H.; Braat, A. E.; de Bruijne, J.; Bruno, M. J.; Burgmans, M. C.; van Delden, O. M.; Dewulf, M.; Erdmann, J. I.; Hagendoorn, J.; van der Holt, B.; Hoogwater, F. J. H.; Inderson, A.; van der Leij, C.; Mohseny, B.; Poley, J. W.; Smits, M. L. J.; van Vilsteren, F. G. I.; Voermans, R. P.; Zijlstra, I. A. J.; van Driel, L. M. J. W.; Koerkamp, B. Groot
Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014)

利妥昔单抗维持治疗首次完全缓解期的弥漫性大B细胞淋巴瘤患者：HOVON和北欧淋巴瘤组（HOVON-84随机III期研究）的长期结果（临床试验编号：NTR1014）

EUROPEAN JOURNAL OF CANCER
IF7.1
2025-01-010
PRE
Lugtenburg, Pieternella Johanna; Brown, Peter de Nully; van der Hol, Bronno; de Jongh, Eva; Zijlstra, Josee M.
Time-restricted versus standard-duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON-96 trial
HEMASPHERE
IF14.6
2024-12-110
OAAI
Broers, Annoek E. C.; Meijer, Ellen; van der Holt, Bronno; de Jong, Cornelis N.; Nur, Erfan; van Sluis, Geerte L.; Choi, Goda; van Gelder, Michel; Maertens, Johan A.; Kuball, Juergen; Deeren, Dries; Visser-Wisselaar, Heleen A.; Meulendijks, Lamberdina A. H. M.; Cornelissen, Jan J.; HOVON Stem Cell Transplantation Working Grp
Bortezomib before and after high-dose therapy in transplant-eligible patients with newly diagnosed multiple myeloma: Long-term overall survival after more than 10 years of follow-up from the phase III HOVON-65/GMMG-HD4 trial
HEMASPHERE
IF14.6
2024-11-200
OAAI
Mai, Elias K.; Nogai, Axel; Lokhorst, Henk M.; van der Holt, Bronno; Zweegman, Sonja; Weisel, Katja C.; Croockewit, Sandra; Jauch, Anna; Hillengass, Jens; Stevens-Kroef, Marian; Raab, Marc S.; Broijl, Annemiek; Bos, Gerard M. J.; Brossart, Peter; Ypma, Paula; Hanoun, Christine; Bertsch, Uta; Hielscher, Thomas; Salwender, Hans J.; Scheid, Christoph; Goldschmidt, Hartmut; Sonneveld, Pieter
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation
BLOOD ADVANCES
IF7.1
2023-12-2918
OAAI
Frerichs, Kristine A.; Verkleij, Christie P. M.; Mateos, Maria Victoria; Martin, Thomas G.; Rodriguez, Cesar; Nooka, Ajay; Banerjee, Arnob; Chastain, Katherine; Perales-Puchalt, Alfredo; Stephenson, Tara; Uhlar, Clarissa; Kobos, Rachel; van der Holt, Bronno; Kruyswijk, Sandy; Kuipers, Maria T.; Groen, Kaz; Vishwamitra, Deeksha; Skerget, Sheri; Cortes-Selva, Diana; Doyle, Margaret; Zaaijer, Hans L.; Zweegman, Sonja; Verona, Raluca I.; van de Donk, Niels W. C. J.
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients
LEUKEMIA
IF13.4
2023-12-078
OAAI
Mai, Elias K.; Hielscher, Thomas; Bertsch, Uta; Salwender, Hans J.; Zweegman, Sonja; Raab, Marc S.; Munder, Markus; Pantani, Lucia; Mancuso, Katia; Brossart, Peter; Beksac, Meral; Blau, Igor W.; Duerig, Jan; Besemer, Britta; Fenk, Roland; Reimer, Peter; van der Holt, Bronno; Haenel, Mathias; von Metzler, Ivana; Graeven, Ullrich; Mueller-Tidow, Carsten; Boccadoro, Mario; Scheid, Christof; Dimopoulos, Meletios A.; Hillengass, Jens; Weisel, Katja C.; Cavo, Michele; Sonneveld, Pieter; Goldschmidt, Hartmut
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study
NEURO-ONCOLOGY
IF13.4
2023-12-011
OAAI
Bromberg, Jacoline E. C.; Issa, Samar; van der Holt, Bronno; van der Meulen, Matthijs; Dirven, Linda; Minnema, Monique C.; Seute, Tatjana; Durian, Marc; Cull, Gavin; van der Poel, Marjolein W. M.; Stevens, Wendy B. C.; Zijlstra, Josee M.; Brandsma, Dieta; Nijland, Marcel; Mason, Kylie D.; Beeker, Aart; Abrahamse-Testroote, Martine C. J.; van den Bent, Martin J.; de Jong, Daphne; Doorduijn, Jeanette K.
Neoadjuvant chemotherapy with FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): A multicenter randomized controlled trial
ANNALS OF ONCOLOGY
IF65.4
2023-10-0119
PRE
Koerkamp, B. Groot; Janssen, Q. P.; van Dam, J. L.; Bonsing, B. A.; Bos, H.; Bosscha, K. P.; Haberkorn, B. C. M.; de Hingh, I. H. J. T.; Karsten, T. M.; Van der Kolk, M. B.; Liem, M. S. L.; Loosveld, O. J. L.; Patijn, G. A.; van Santvoort, H. C. M.; de Vos-Geelen, J.; van der Holt, B.; Homs, M. Y. V.; van Tienhoven, G.; Besselink, M. G.; Wilmink, H. W.
Transarterial Chemoembolization With Drug- Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial)
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
IF6.5
2023-09-0126
OAAI
Romero, Alejandra Mendez; van der Holt, Bronno; Willemssen, Francois E. J. A.; de Man, Rob A.; Heijmen, Ben J. M.; Habraken, Steven; Westerveld, Henrike; van Delden, Otto M.; Klumpen, Heinz-Josef; Tjwa, Eric T. T. L.; Braam, Petra M.; Jenniskens, Sjoerd F. M.; Vanwolleghem, Thomas; Weytjens, Reinhilde; d'Archambeau, Olivier; de Vos-Geelen, Judith; Buijsen, Jeroen; van der Leij, Christiaan; den Toom, Wilhelm; Sprengers, Dave; Ijzermans, Jan N. M.; Moelker, Adriaan
Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13
HEMASPHERE
IF14.6
2023-09-011
OAAI
Groen, Kazimierz; Schjesvold, Fredrik H.; van der Holt, Bronno; Levin, Mark-David; Seefat, Maarten R.; Hansson, Markus; Leys, Maria B. L.; Regelink, Josien C.; Waage, Anders; Szatkowski, Damian; Axelsson, Per; Hieu Do, Trung; Svirskaite, Asta; van der Spek, Ellen; Haukas, Einar; Knut-Bojanowska, Dorota; Ypma, Paula F.; Blimark, Cecilie H.; Mellqvist, Ulf-Henrik; van de Donk, Niels W. C. J.; Sonneveld, Pieter; Klostergaard, Anja; Vangsted, Annette J.; Abildgaard, Niels; Zweegman, Sonja
Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial

围手术期或辅助mFOLFIRINOX治疗可切除胰腺癌 (PREOPANC-3): 一项多中心随机对照试验的研究方案

BMC CANCER
IF3.4
2023-08-0726
OAAI
van Dam, J. L.; Verkolf, E. M. M.; Dekker, E. N.; Bonsing, B. A.; Bratlie, S. O.; Brosens, L. A. A.; Busch, O. R.; van Driel, L. M. J. W.; van Eijck, C. H. J.; Feshtali, S.; Ghorbani, P.; de Groot, D. J. A.; de Groot, J. W. B.; Haberkorn, B. C. M.; de Hingh, I. H.; van der Holt, B.; Karsten, T. M.; van der Kolk, M. B.; Labori, K. J.; Liem, M. S. L.; Loosveld, O. J. L.; Molenaar, I. Q.; Polee, M. B.; van Santvoort, H. C.; de Vos Geelen, J.; Wumkes, M. L.; van Tienhoven, G.; Homs, M. Y. V.; Besselink, M. G.; Wilmink, J. W.; Groot Koerkamp, B.

研究方向

暂未获取到该数据
P
Pieter Sonneveld
H 指数:126论文数:1,252被引数:7.6万
S
Sonja Zweegman
H 指数:87论文数:772被引数:3.2万
J
Jan J. Cornelissen
H 指数:78论文数:612被引数:3.1万
M
Martin J. van den Bent
H 指数:128论文数:1,361被引数:10.0万
H
H M Lokhorst
H 指数:45论文数:170被引数:6,233
G
Gerard M.J. Bos
H 指数:43论文数:221被引数:9,001
W
Walter Taal
H 指数:31论文数:191被引数:6,357
H
Hartmut Goldschmidt
H 指数:109论文数:1,437被引数:6.4万
A
Anders Waage
H 指数:67论文数:320被引数:1.9万
E
Edo Vellenga
H 指数:97论文数:846被引数:3.9万